Tirzepatide vs Semaglutide: Which GLP-1 Medication Is Better?
Gut Friendly GLP1 Support
FODMAP Digestive Enzymes + Prebiotics + Probiotics + Postbiotics Gut Friendly Low FODMAP MD PhD Formulated$29.89Shop Now →
Elemental Vegan Protein Powder | Low FODMAP Plant-Based Nutrition Support$57.99Shop Now →
Elemental Whey WPI Protein Powder + Digestive Enzymes (Chocolate) | Low FODMAP & GLP-1 Gut-Gentle Muscle Support$57.99Shop Now →
Vitamin & Mineral Gummies | Low FODMAP & GLP-1 Daily Essential Nutrition$22.99Shop Now →
FODMAP Digestive Enzymes | Low FODMAP Gut Friendly Support for Heavy Meals & Bloating$29.99Shop Now →
Advanced Probiotic & Prebiotic | Low FODMAP Daily Gut Health & Microbiome Balance$45.99Shop Now →
Advanced Probiotics GI Support Low FODMAP Gut Friendly MD PhD Formulated$22.99Shop Now →
Elemental Whey WPI Protein Powder + Digestive Enzymes (Vanilla) | Low FODMAP & GLP-1 Gut-Gentle Muscle Support$57.99Shop Now →
Herbal Laxative 15 Day Colon Cleanse Low FODMAP Gut Friendly Gentle Motility Support$22.99Shop Now →
The Menopause Gut-Hormone Reset Protocol (MD PhD Formulated)$67.89Shop Now →
Elemental Collagen Peptides | Low FODMAP & GLP-1 Gentle Protein for Hair, Skin & Joints$57.99Shop Now →
Tirzepatide vs Semaglutide: Which GLP-1 Medication Is Better?
By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist
This is the biggest question in weight loss medicine right now. Tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) are both GLP-1 receptor agonists, but tirzepatide has a second mechanism — GIP receptor agonism — that changes the game. Here's the head-to-head data.
Key Takeaways
- Tirzepatide is a dual GLP-1/GIP agonist; semaglutide is GLP-1 only
- SURMOUNT-5 head-to-head: tirzepatide produced ~20% weight loss vs ~14% for semaglutide
- Tirzepatide may be better for blood sugar control AND weight loss
- Side effect profiles are similar, with tirzepatide potentially causing more GI issues at high doses
- Both require the same GI support protocol: GLP-1 Digestive Enzyme Companion
Head-to-Head Comparison
| Feature | Tirzepatide (Mounjaro/Zepbound) | Semaglutide (Ozempic/Wegovy) |
|---|---|---|
| Mechanism | GLP-1 + GIP dual agonist | GLP-1 agonist only |
| Weight loss | ~20-22% at max dose | ~14-16% at max dose |
| A1C reduction | -2.1% (superior) | -1.9% |
| Max dose | 15mg weekly | 2.4mg weekly |
| Nausea rate | ~30-35% | ~40-44% |
| Manufacturer | Eli Lilly | Novo Nordisk |
| Oral form | Not yet available | Rybelsus (oral semaglutide) |
GI Side Effect Management (Same for Both)
- GLP-1 Digestive Enzyme Companion with every meal
- Daily probiotics for microbiome support
- Psyllium fiber for constipation
- Low FODMAP protein to preserve muscle mass
See our detailed guides: Ozempic vs Wegovy, Mounjaro vs Zepbound, muscle loss prevention.
This article is educational only. Medication selection requires medical evaluation and consideration of individual health factors.
